WASHINGTON, Sept 22 (Reuters) - The Trump administration has asked drug companies to be prepared to ramp up production of leucovorin as a treatment for some autism patients, FDA chief Marty Makary told reporters on Monday.
(Reporting by Jeff Mason and Steve Holland; Editing by Chris Reese)
((Steve.a.holland@thomsonreuters.com; www.twitter.com/steveholland1; 202 898 8300; Reuters Messaging: steve.holland.reuters.com@reuters.net))